Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Ovarian Cancer Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Preclinical Research, And Discovery Stage Highlights Report 2016-2019 - Research and Markets

Research and Markets
Posted on: 01 Dec 16

Research and Markets has announced the addition of the "Ovarian Cancer Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Ovarian Cancer Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Ovarian Cancer market. It covers emerging therapies for Ovarian Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Scope of the Report

Clinical Trial Stages:

The report provides Ovarian Cancer pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Ovarian Cancer pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Ovarian Cancer pipeline products by the company.

Short-term Launch Highlights:

Find out which Ovarian Cancer pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Ovarian Cancer Pipeline by Stages

2. Ovarian Cancer Pipeline by Drug Class

3. Ovarian Cancer Pipeline by Company

4. Ovarian Cancer Phase 3 Clinical Trial Insights

5. Ovarian Cancer Phase 2 Clinical Trial Insights

6. Ovarian Cancer Phase 1 Clinical Trial Insights

7. Ovarian Cancer Preclinical Research Insights

8. Ovarian Cancer Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/b7b5wm/ovarian_cancer

View source version on businesswire.com: http://www.businesswire.com/news/home/20161201005718/en/

Business Wire
www.businesswire.com

Last updated on: 01/12/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.